# Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

> **NCT00005012** · PHASE2 · COMPLETED · sponsor: **Schering-Plough** · enrollment: 250 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Peginterferon alfa-2b

## Key facts

- **NCT ID:** NCT00005012
- **Lead sponsor:** Schering-Plough
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 250 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005012, "Safety and Effectiveness of PEG-Intron in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*